MYC and hepatocellular carcinoma: C-Myc-activated LncCCAT1 can promote proliferation and invasion of colon cancer cells, gastric cancer cells, hepatoma cells and pancreatic cancer cells 26, 27 and reduce cell radiosensitivity by regulating miR-148b in breast cancer cells 28.